Adaptin Bio, Inc. Sale of Stock, Consideration Received on Transaction
Adaptin Bio, Inc. (APTN) had Sale of Stock, Consideration Received on Transaction of $4 as of 2025-10-29, per its S-1 filed 2026-08-28.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-08-28
- 2025-10-29: Sale of Stock, Consideration Received on Transaction $4.00.
| Period end | Sale of Stock, Consideration Received on Transaction |
|---|---|
| 2025-10-29 | $4.00 S-1 · filed 2026-08-28 |